Clinical Trial Update: Effects of Travatan Z and Xalatan on Ocular Surface Health [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the effects of Travatan Z and Xalatan on ocular surface health in patients with glaucoma or ocular hypertension; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)
• Xalatan (latanoprost)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-04-23